---
figid: PMC7712612__13046_2020_1784_Fig3_HTML
figtitle: MIR22HG is involved in signaling pathways that affect cancer progression
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC7712612
filename: 13046_2020_1784_Fig3_HTML.jpg
figlink: pmc/articles/PMC7712612/figure/Fig3/
number: F3
caption: MIR22HG is involved in signaling pathways that affect cancer progression.
  a MIR22HG negatively regulates the Wnt/β-catenin signaling pathway by downregulating
  the expression of β-catenin, cyclin D1 and c-myc to inhibit cell proliferation and
  migration in CCA. b MIR22HG blocks the SMAD complex, preventing its binding to the
  promoter of SNAI1 and further suppressing the EMT signaling pathway. c MIR22HG inhibits
  the Notch signaling pathway by downregulating nuclear Notch2 and HEY1 expression
  in GC. d MIR22HG activates the STAT3 signaling pathway to promote the proliferation,
  migration and invasion of ESCA
papertitle: Emerging impact of the long noncoding RNA MIR22HG on proliferation and
  apoptosis in multiple human cancers.
reftext: Le Zhang, et al. J Exp Clin Cancer Res. 2020;39:271.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9118038
figid_alias: PMC7712612__F3
figtype: Figure
redirect_from: /figures/PMC7712612__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7712612__13046_2020_1784_Fig3_HTML.html
  '@type': Dataset
  description: MIR22HG is involved in signaling pathways that affect cancer progression.
    a MIR22HG negatively regulates the Wnt/β-catenin signaling pathway by downregulating
    the expression of β-catenin, cyclin D1 and c-myc to inhibit cell proliferation
    and migration in CCA. b MIR22HG blocks the SMAD complex, preventing its binding
    to the promoter of SNAI1 and further suppressing the EMT signaling pathway. c
    MIR22HG inhibits the Notch signaling pathway by downregulating nuclear Notch2
    and HEY1 expression in GC. d MIR22HG activates the STAT3 signaling pathway to
    promote the proliferation, migration and invasion of ESCA
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Smad2
  - Mir22hg
  - Smad4
  - Snai1
  - Ctnnb1
  - Ccnd1
  - Myc
  - Nol3
  - Cdh1
  - Fzr1
  - Tjp1
  - Cdh2
  - Stat3
  - Hey1
  - Notch2
  - Ptk2
  - SMAD2
  - MIR22HG
  - SMAD4
  - SNAI1
  - CTNNB1
  - CCND1
  - MYC
  - CDH1
  - FZR1
  - TJP1
  - CDH2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CD8A
  - CD8B
  - STAT3
  - HEY1
  - NOTCH2
  - NOTCH1
  - NOTCH3
  - NOTCH4
  - PTK2
  - smad2
  - smad4a
  - smad4b
  - snai1a
  - ctnnb1
  - ccnd1
  - myca
  - mt
  - cdh1
  - si:busm1-180o5.1
  - si:busm1-180o5.2
  - cdh2
  - stat3
  - hey1
  - notch2
  - ptk2ab
  - cholangiocarcinoma
  - colorectal cancer
  - gastric cancer
  - esophageal carcinoma
---
